% Expired Patents = 100.0

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 17

Loading Chart...

5 inventors (with patents filed for the assignee):

Stephen J Brand (4 out of 9 patents)

Sheila G Magil (1 out of 3 patents)

Antonio Cruz (1 out of 2 patents)

4. Susan D Jones (1 out of 1 patent)

5. Gary William Pace (1 out of 16 patents)

6. Ronald V Nardi (11 patents)

7. Linda Kurdydyk (0 patent)

4 patents: Sort by Forward Citations

1. 7560425 - Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes (2009-07-14),

2. 7476388 - Composition comprising a gastrin/CCK receptor ligand and an EGF receptor ligand (2009-01-13),

3. 7037504 - Epidermal growth factor protein and gene, and methods of use therefor (2006-05-02),

4. 6992060 - Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes (2006-01-31),

Company Overview

Waratah Pharmaceuticals Inc. is a leading biopharmaceutical company dedicated to discovering, developing, and delivering innovative medications to improve the lives of patients worldwide. With a focus on cutting-edge research and development, Waratah Pharmaceuticals is committed to addressing unmet medical needs and advancing healthcare solutions. Our dedication to scientific excellence and patient care drives everything we do.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#352 in Toronto

#3,464 in Canada

Toronto, Canada

Waratah Pharmaceuticals Inc.

Forward Citations = 17

5 inventors:

Stephen J Brand (4 out of 9 patents)

Sheila G Magil (1 out of 3 patents)

Antonio Cruz (1 out of 2 patents)

4. Susan D Jones (1 out of 1 patent)

5. Gary William Pace (1 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Waratah Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/waratah-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]